CPT® Code 86665

The CPT® Code 86665 refers to a laboratory test that measures antibodies against the Epstein-Barr virus (EBV), specifically targeting the viral capsid antigen (VCA). This test is crucial for diagnosing infections caused by EBV, which is known to lead to infectious mononucleosis, a common viral illness primarily affecting children and young adults. Infectious mononucleosis is typically characterized by a range of symptoms including fever, fatigue, sore throat, swollen lymph nodes, and in some cases, an enlarged spleen. The transmission of EBV occurs through saliva, particularly during active infection, and the virus can persist in the body’s lymphocytes for life, with potential reactivation occurring without noticeable symptoms. In addition to infectious mononucleosis, EBV is associated with several serious conditions, including X-linked lymphoproliferative syndrome in males and various malignancies such as Burkitt lymphoma, Hodgkin's lymphoma, and nasopharyngeal carcinoma. The antibody tests related to EBV, including the early antigen (EA) IgG antibody test (CPT® Code 86663) and the EBV nuclear antigen (EBNA) IgG antibody test (CPT® Code 86664), are utilized to provide a comprehensive understanding of a patient's exposure to the virus and the status of their immune response. The VCA test for IgG and IgM antibodies, represented by CPT® Code 86665, is particularly valuable for diagnosing primary EBV infectious mononucleosis when used in conjunction with other diagnostic tests. However, it is important to note that the VCA test for IgA antibodies is not suitable for diagnosing infectious mononucleosis but may assist in the detection and prognosis of nasopharyngeal carcinoma. The testing process involves obtaining a blood sample through venipuncture, and the serum is analyzed using a semi-quantitative chemiluminescent immunoassay, ensuring accurate measurement of the antibodies present.